• 1
    Powe CE, Levine RJ & Karumanchi SA (2011) Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 123, 28562869.
  • 2
    Banek CT & Gilbert JS (2011) Approaching the threshold for predicting preeclampsia: monitoring angiogenic balance during pregnancy. Hypertension 58, 774775.
  • 3
    Verlohren S, Stepan H & Dechend R (2012) Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. Clin Sci 122, 4352.
  • 4
    Redman CW & Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308, 15921594.
  • 5
    Shi Y, Hu G & Su J (2010) Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res 20, 510518.
  • 6
    Kasper G, Dankert N, Tuischer J, Hoeft M, Gaber T, Glaeser JD, Zander D, Tschirschmann M, Thompson M, Matziolis G et al. (2007) Mesenchymal stem cells regulate angiogenesis according to their mechanical environment. Stem Cells 25, 903910.
  • 7
    Ishii M, Shibata R, Numaguchi Y, Kito T, Suzuki H, Shimizu K, Ito A, Honda H & Murohara T (2011) Enhanced angiogenesis by transplantation of mesenchymal stem cell sheet created by a novel magnetic tissue engineering method. Arterioscler Thromb Vasc Biol 31, 22102215.
  • 8
    Chen J, Park HC, Addabbo F, Ni J, Pelger E, Li H, Plotkin M & Goligorsky MS (2008) Kidney-derived mesenchymal stem cells contribute to vasculogenesis, angiogenesis and endothelial repair. Kidney Int 74, 879889.
  • 9
    Castrechini NM, Murthi P, Gude NM, Erwich JJ, Gronthos S, Zannettino A, Brennecke SP & Kalionis B (2010) Mesenchymal stem cells in human placental chorionic villi reside in a vascular niche. Placenta 31, 203212.
  • 10
    Hwang JH, Lee MJ, Seok OS, Paek YC, Cho GJ, Seol HJ, Lee JK & Oh MJ (2010) Cytokine expression in placenta-derived mesenchymal stem cells in patients with pre-eclampsia and normal pregnancies. Cytokine 49, 95101.
  • 11
    Inui M, Martello G & Piccolo S (2010) MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 11, 252263.
  • 12
    Tome M, Lopez-Romero P, Albo C, Sepulveda JC, Fernandez-Gutierrez B, Dopazo A, Bernad A & Gonzalez MA (2011) miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells. Cell Death Differ 18, 985995.
  • 13
    Huang J, Zhao L, Xing L & Chen D (2010) MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells 28, 357364.
  • 14
    Kim YJ, Hwang SJ, Bae YC & Jung JS (2009) MiR-21 regulates adipogenic differentiation through the modulation of TGF-β signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells 27, 30933102.
  • 15
    Noack F, Ribbat-Idel J, Thorns C, Chiriac A, Axt-Fliedner R, Diedrich K & Feller AC (2011) miRNA expression profiling in formalin-fixed and paraffin-embedded placental tissue samples from pregnancies with severe preeclampsia. J Perinat Med 39, 267271.
  • 16
    Pineles BL, Romero R, Montenegro D, Tarca AL, Han YM, Kim YM, Draghici S, Espinoza J, Kusanovic JP, Mittal P et al. (2007) Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol 196, 261.e1261.e6.
  • 17
    Zhu XM, Han T, Sargent IL, Yin GW & Yao YQ (2009) Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. Am J Obstet Gynecol 200, 661.e1661.e7.
  • 18
    Hu Y, Li P, Hao S, Liu L, Zhao J & Hou Y (2009) Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia. Clin Chem Lab Med 47, 923929.
  • 19
    Liu C, Zhou Y & Zhang Z (2012) MiR-210: an important player in the pathogenesis of preeclampsia? J Cell Mol Med 16, 943944.
  • 20
    Zhang Y, Diao Z, Su L, Sun H, Li R, Cui H & Hu Y (2010) MicroRNA-155 contributes to preeclampsia by down-regulating CYR61. Am J Obstet Gynecol 202, 466.e1466.e7.
  • 20a
    Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25, 2529.
  • 20b
    Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, Georgescu C & Romero R (2007) A systems biology approach for pathway level analysis. Genome Res 17, 15371545.
  • 20c
    Lockwood CJ, Huang SJ, Krikun G, Caze R, Rahman M, Buchwalder LF & Schatz F (2011) Decidual hemostasis, inflammation, and angiogenesis in pre-eclampsia. Semin Thromb Hemost 37, 158164.
  • 21
    Liu Q, Fu H, Sun F, Zhang H, Tie Y, Zhu J, Xing R, Sun Z & Zheng X (2008) miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res 36, 53915404.
  • 22
    Ferrara N (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25, 581611.
  • 23
    Folkman J (2006) Angiogenesis. Annu Rev Med 57, 118.
  • 24
    Bianco P, Robey PG & Simmons PJ (2008) Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2, 313319.
  • 24a
    Collino F, Bruno S, Deregibus MC, Tetta C & Camussi G (2011) MicroRNAs and mesenchymal stem cells. Vitam Horm 87, 291320.
  • 25
    Cudihy D & Lee RV (2009) The pathophysiology of pre-eclampsia: current clinical concepts. J Obstet Gynaecol 29, 576582.
  • 26
    Winn VD, Gormley M & Fisher SJ (2011) The impact of preeclampsia on gene expression at the maternal–fetal interface. Pregnancy Hypertens 1, 100108.
  • 27
    Heazell AE, Brown M, Worton SA & Dunn WB (2011) The effects of oxygen on normal and pre-eclamptic placental tissue – insights from metabolomics. Placenta 32(Suppl. 2), S119S124.
  • 28
    Rolfo A, Many A, Racano A, Tal R, Tagliaferro A, Ietta F, Wang J, Post M & Caniggia I (2010) Abnormalities in oxygen sensing define early and late onset preeclampsia as distinct pathologies. PLoS One 5, e13288.
  • 29
    Liu L, Wang Y, Fan H, Zhao X, Liu D, Hu Y, Kidd ARIII, Bao J & Hou Y (2012) MicroRNA-181a regulates local immune balance by inhibiting proliferation and immunosuppressive properties of mesenchymal stem cells. Stem Cells 30, 17561770.
  • 30
    Balakrishnan A, Stearns AT, Park PJ, Dreyfuss JM, Ashley SW, Rhoads DB & Tavakkolizadeh A (2010) MicroRNA mir-16 is anti-proliferative in enterocytes and exhibits diurnal rhythmicity in intestinal crypts. Exp Cell Res 316, 35123521.
  • 31
    Wang K, Li P, Dong Y, Cai X, Hou D, Guo J, Yin Y, Zhang Y, Li J, Liang H et al. (2011) A microarray-based approach identifies ADP ribosylation factor-like protein 2 as a target of microRNA-16. J Biol Chem 286, 94689476.
  • 32
    Bandi N, Zbinden S, Gugger M, Arnold M, Kocher V, Hasan L, Kappeler A, Brunner T & Vassella E (2009) miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res 69, 55535559.
  • 33
    Linsley PS, Schelter J, Burchard J, Kibukawa M, Martin MM, Bartz SR, Johnson JM, Cummins JM, Raymond CK, Dai H et al. (2007) Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol 27, 22402252.
  • 34
    Chamorro-Jorganes A, Araldi E, Penalva LO, Sandhu D, Fernandez-Hernando C & Suarez Y (2011) MicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1. Arterioscler Thromb Vasc Biol 31, 25952606.
  • 35
    Shyu MK, Chen CW, Lin NY, Liao WC, Chen CH, Lin CJ, Huang HC, Lee JJ, Huang MJ, Tseng GF et al. (2011) MUC1 expression is elevated in severe preeclamptic placentas and suppresses trophoblast cell invasion via β1-integrin signaling. J Clin Endocrinol Metab 96, 37593767.
  • 36
    Fan Gm Zhao G, Liu L, Liu F, Gong W, Liu X, Yang L, Wang J & Hou Y (2012) Pre-treatment with IL-1b enhances the efficacy of MSC transplantation in DSS-induced colitis. Cellular & Molecular Immunology 9, 473481.